EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach

Anjana C Lalu, Varun Thachan Kundil iD, Bristow Ben Joseph iD, Radul R Dev iD, Amritha Thaikkad, Suhail Subair, Rajesh Raju iD, Abhithaj Jayanandan iD

Viruses · 13.12.2025 · 17 (12) · 1613

DOI: 10.3390/v17121613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 13.12.2025. Verfasst von Anjana C Lalu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangaluru 575018, Karnataka, India. Hauptthemen laut MEDLINE: RNA-Dependent RNA Polymerase, Hendra Virus, Antiviral Agents, Drug Repositioning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hendra virus (HeV) is a highly pathogenic zoonotic paramyxovirus that poses a serious threat to human and equine health, yet no approved antivirals or vaccines currently exist. RNA-dependent RNA polymerase (RdRp) of Hendra virus represents a critical and attractive target for antiviral drug development, given its essential role in both viral genome replication and mRNA transcription. Due to the lack of a human homolog, it is more druggable and less likely to cause host toxicity. Its sequence conservation among related paramyxoviruses further highlights its potential for the development of broad-spectrum inhibitors. This study offers the first comprehensive computational analysis of the Hendra virus RdRp, potentially promising FDA-approved drugs as possible inhibitors. A homology model of RdRp was generated in the absence of experimental three-dimensional (3D) structure, followed by virtual screening and molecular dynamics (MD) simulations to evaluate the drug binding and stability. Based on the highest energy, four FDA-approved drugs selected were menadiol diphosphate (−49.88 kcal/mol), masoprocol (−39.69 kcal/mol), pamidronic acid (−34.29 kcal/mol), and dinoprostone (−46.90 kcal/mol). Furthermore, these compounds exhibited significant interactions with the catalytic GDNE motif. With strong conformational stability and pharmacokinetic profile, masoprocol and menadiol diphosphate showed the most stable and energetically favorable interactions within the RdRp active site. These findings suggest their potential as repurposed therapeutic candidates against Hendra virus infection and they provide a structural basis for the development of broad-spectrum paramyxovirus inhibitors, justifying additional experimental confirmation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Dependent RNA PolymeraseHendra VirusAntiviral AgentsDrug RepositioningEnzyme InhibitorsMolecular Dynamics SimulationDrug DiscoveryHumansAnimalsUnited StatesComputational BiologyMolecular Docking Simulation

Stichwörter der Autor:innen

FDA-approved drugsRNA-dependent RNA polymerasehendra virusmolecular dynamics

Substanzen

RNA-Dependent RNA PolymeraseAntiviral AgentsEnzyme Inhibitors

Autor:innen und Institutionen

  • Centre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangaluru 575018, Karnataka, India.

ORCID-Profile: Varun Thachan Kundil, Bristow Ben Joseph, Radul R Dev, Rajesh Raju, Abhithaj Jayanandan

Zitieren

APA

Lalu, A. C., Kundil, V. T., Joseph, B. B., Dev, R. R., Thaikkad, A., Subair, S., Raju, R., & Jayanandan, A. (2025). Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach. Viruses, 17(12), 1613. https://doi.org/10.3390/v17121613

Vancouver

Lalu AC, Kundil VT, Joseph BB, Dev RR, Thaikkad A, Subair S, et al. Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach. Viruses. 2025;17(12):1613. doi:10.3390/v17121613

BibTeX
@article{Lalu2025,
  author = {Lalu, Anjana C and Kundil, Varun Thachan and Joseph, Bristow Ben and Dev, Radul R and Thaikkad, Amritha and Subair, Suhail and Raju, Rajesh and Jayanandan, Abhithaj},
  title = {Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {12},
  pages = {1613},
  doi = {10.3390/v17121613}
}
Kostenlos starten →